Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis

被引:157
作者
Dong, Chao-Hui [1 ]
Wang, Zhang-Min [1 ]
Chen, Si-Yu [2 ]
机构
[1] Chongqing Med Univ, Affiliated Rehabil Hosp, Dept Cardiopulm Rehabil, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 1, Dept Vasc Surg, Chongqing, Peoples R China
关键词
Neutrophil to lymphocyte ratio; Acute coronary syndrome; Mortality; Major adverse cardiac events; ELEVATION MYOCARDIAL-INFARCTION; LONG-TERM MORTALITY; NEUTROPHIL/LYMPHOCYTE RATIO; ARTERY-DISEASE; PRETREATMENT NEUTROPHIL; CLINICAL-OUTCOMES; PROGNOSTIC VALUE; TRIAL; INTERVENTION; SCORE;
D O I
10.1016/j.clinbiochem.2017.11.008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Objectives: Neutrophil to lymphocyte ratio (NLR) might be associated with the mortality or major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients. We performed a meta-analysis to evaluate the correlation between NLR and mortality/MACEs in ACS. Methods: We assessed clinical trials through Pubmed, EMBASE, the Cochrane Library and Web of science in investigating the association between NLR and mortality/MACEs in ACS patients up to August 15, 2017. The primary outcome was mortality or recurrent MACEs. Results: In total, 8 studies of 9406 patients were included in the systematic and meta-analysis. Our analysis indicated that elevated pretreatment NLR was a poor prognostic marker for patients with recent ACS in predicting medium to long-term mortality/MACEs (OR 1.26, 95% CI 1.13-1.41). And the analysis indicated that higher pretreatment NLR value was associated with higher in-hospital mortality in ACS patients (OR 6.39, 95% CI 1.49-27.38, p < 0.001). The NLR value of 5.0 maybe a cut-off value for ACS risk. Conclusions: In patients with a recent ACS, an elevated pretreatment NLR value is effective in predicting the risk of mortality/MACEs.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 32 条
[1]
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography [J].
Arbel, Yaron ;
Finkelstein, Ariel ;
Halkin, Amir ;
Birati, Edo Y. ;
Revivo, Miri ;
Zuzut, Meital ;
Shevach, Ayala ;
Berliner, Shlomo ;
Herz, Itzhak ;
Keren, Gad ;
Banai, Shmuel .
ATHEROSCLEROSIS, 2012, 225 (02) :456-460
[2]
Usefulness of Neutrophil to Lymphocyte Ratio in Predicting Short- and Long-Term Mortality After Non-ST-Elevation Myocardial Infarction [J].
Azab, Basem ;
Zaher, Medhat ;
Weiserbs, Kera F. ;
Torbey, Estelle ;
Lacossiere, Kenson ;
Gaddam, Sainath ;
Gobunsuy, Romel ;
Jadonath, Sunil ;
Baldari, Duccio ;
McCord, Donald ;
Lafferty, James .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (04) :470-476
[3]
Bajari R, 2017, INDIAN HEART J, V69, pS46, DOI 10.1016/j.ihj.2017.01.020
[4]
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme [J].
Bambury, R. M. ;
Teo, M. Y. ;
Power, D. G. ;
Yusuf, A. ;
Murray, S. ;
Battley, J. E. ;
Drake, C. ;
O'Dea, P. ;
Bermingham, N. ;
Keohane, C. ;
Grossman, S. A. ;
Moylan, E. J. ;
O'Reilly, S. .
JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) :149-154
[5]
Predictive value of elevated neutrophil-lymphocyte ratio for left ventricular systolic dysfunction in patients with non ST-elevated acute coronary syndrome [J].
Bekler, Adem ;
Erbag, Gokhan ;
Sen, Hacer ;
Gazi, Emine ;
Ozcan, Sedat .
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (01) :159-163
[6]
Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Ischemic Cerebrovascular Disease [J].
Celikbilek, Asuman ;
Ismailogullari, Sevda ;
Zararsiz, Gokmen .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2014, 28 (01) :27-31
[7]
5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial A Randomized Comparison of an Early Invasive Versus Selective Invasive Management in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome [J].
Damman, Peter ;
Hirsch, Alexander ;
Windhausen, Fons ;
Tijssen, Jan G. P. ;
de Winter, Robbert J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (09) :858-864
[8]
The Predictive Value of Total Neutrophil Count and Neutrophil/Lymphocyte Ratio in Predicting In-hospital Mortality and Complications after STEMI [J].
Ghaffari, Samad ;
Nadiri, Mehdi ;
Pourafkari, Leili ;
Sepehrvand, Nariman ;
Movasagpoor, Aliakbar ;
Rahmatvand, Neda ;
Saatloo, Mohammadamin Rezazadeh ;
Ahmadi, Mona ;
Nader, Nader D. .
JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2014, 6 (01) :35-41
[9]
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial [J].
Goldstein, David ;
El-Maraghi, Robert Hassan ;
Hammel, Pascal ;
Heinemann, Volker ;
Kunzmann, Volker ;
Sastre, Javier ;
Scheithauer, Werner ;
Siena, Salvatore ;
Tabernero, Josep ;
Teixeira, Luis ;
Tortora, Giampaolo ;
Van Laethem, Jean-Luc ;
Young, Rosemary ;
Penenberg, Darryl Neil ;
Lu, Brian ;
Romano, Alfredo ;
Von Hoff, Daniel D. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (02)
[10]
Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation A systematic review on more than 34,000 subjects [J].
Guasti, Luigina ;
Dentali, Francesco ;
Castiglioni, Luana ;
Maroni, Lorenzo ;
Marino, Franca ;
Squizzato, Alessandro ;
Ageno, Walter ;
Gianni, Monica ;
Gaudio, Giovanni ;
Grandi, Anna M. ;
Cosentino, Marco ;
Venco, Achille .
THROMBOSIS AND HAEMOSTASIS, 2011, 106 (04) :591-599